TY - JOUR
T1 - European central hypoventilation syndrome consortium description of congenital central hypoventilation syndrome neonatal onset
AU - Dudoignon, Benjamin
AU - Peters, Jochen
AU - Paglietti, Maria Giovanna
AU - Garcia Teresa, Maria Angeles
AU - Samuels, Martin
AU - Markstrom, Agneta
AU - Madureira, Nuria
AU - Chaitidou-Kolb, Panagiota
AU - Bokov, Plamen
AU - Delclaux, Christophe
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2025.
PY - 2025/2
Y1 - 2025/2
N2 - It is known that in most cases of congenital central hypoventilation syndrome (CCHS), apnoeas and hypoventilation occur at birth. Nevertheless, a detailed description of initial symptoms, including pregnancy events and diagnostic tests performed, is warranted in infants with neonatal onset of CCHS, that is, in the first month of life. The European Central Hypoventilation Syndrome Consortium created an online patient registry from which 97 infants (44 females) with CCHS of neonatal onset and PHOX2B mutation from 10 countries were selected. The typical pregnancy is characterized by polyhydramnios (44%), fetal heart rate abnormalities on cardiotocography (36%), emergency cesarean sections. (30%) and a normal gestational age (14% preterm birth). The typical findings within the first days are the presence of respiratory distress (96%), often necessitating rapid intubation (44%) and, less frequently, cardiopulmonary resuscitation at birth (14%). These symptoms lead to a suspicion of CCHS after (median [interquartile]) 7 days [4; 12] since birth that is confirmed by genotype testing at 32 days [22; 61]. Daytime evaluation of blood gas is a frequent assessment leading to CCHS suspicion (n = 61/97, 63%; 95% confidence interval: 52–72) while a polysomnography is obtained in 45/97 infants (46%, 95% confidence interval: 36–57), demonstrating NREM hypoventilation in 44/45 infants (98%). Conclusion: Our multicentre descriptive study shows that polyhydramnios is overrepresented during pregnancy, rapid respiratory failure is the main symptom leading to intubation in approximately half of infants and daytime alveolar hypoventilation is the main indicator prompting genetic testing. (Table presented.).
AB - It is known that in most cases of congenital central hypoventilation syndrome (CCHS), apnoeas and hypoventilation occur at birth. Nevertheless, a detailed description of initial symptoms, including pregnancy events and diagnostic tests performed, is warranted in infants with neonatal onset of CCHS, that is, in the first month of life. The European Central Hypoventilation Syndrome Consortium created an online patient registry from which 97 infants (44 females) with CCHS of neonatal onset and PHOX2B mutation from 10 countries were selected. The typical pregnancy is characterized by polyhydramnios (44%), fetal heart rate abnormalities on cardiotocography (36%), emergency cesarean sections. (30%) and a normal gestational age (14% preterm birth). The typical findings within the first days are the presence of respiratory distress (96%), often necessitating rapid intubation (44%) and, less frequently, cardiopulmonary resuscitation at birth (14%). These symptoms lead to a suspicion of CCHS after (median [interquartile]) 7 days [4; 12] since birth that is confirmed by genotype testing at 32 days [22; 61]. Daytime evaluation of blood gas is a frequent assessment leading to CCHS suspicion (n = 61/97, 63%; 95% confidence interval: 52–72) while a polysomnography is obtained in 45/97 infants (46%, 95% confidence interval: 36–57), demonstrating NREM hypoventilation in 44/45 infants (98%). Conclusion: Our multicentre descriptive study shows that polyhydramnios is overrepresented during pregnancy, rapid respiratory failure is the main symptom leading to intubation in approximately half of infants and daytime alveolar hypoventilation is the main indicator prompting genetic testing. (Table presented.).
KW - Congenital central hypoventilation syndrome
KW - Hypoventilation
KW - Polyhydramnios
KW - Pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85217623588&partnerID=8YFLogxK
U2 - 10.1007/s00431-025-05969-1
DO - 10.1007/s00431-025-05969-1
M3 - Article
C2 - 39883186
AN - SCOPUS:85217623588
SN - 0340-6199
VL - 184
JO - European Journal of Pediatrics
JF - European Journal of Pediatrics
IS - 2
M1 - 161
ER -